CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
about
Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic virusesSignificance of CD44 expression in head and neck cancer: a systemic review and meta-analysisModeling nasopharyngeal carcinoma in three dimensions5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesisE3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line.Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinomaCD44 is associated with the aggressive phenotype of nasopharyngeal carcinoma through redox regulationA novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy.Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.The role of Epstein-Barr virus in epithelial malignancies.The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Cancer stem cells in human digestive tract malignancies.Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.c-MYB regulates cell growth and DNA damage repair through modulating MiR-143.Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.Targeting Lung Cancer Stem Cells: Research and Clinical ImpactsEpstein-Barr virus infection and nasopharyngeal carcinoma.Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?Modulation of the Tumor Microenvironment by Epstein-Barr virus Latent Membrane Protein-1 in Nasopharyngeal Carcinoma.XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.The transmembrane transporter ABCC3 participates in liver cancer progression and is a potential biomarker.MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.
P2860
Q26863339-4AA06A97-77A2-4215-863A-B028CF7E2D16Q27023399-9E02D10C-A926-4B9B-A3B9-677201A2ABDBQ33599243-AF86A2A4-F28F-4E72-83A0-A5483F99E6C7Q33884816-A24B9A43-4F50-4C7C-81D0-9F4E58BD1CBEQ34023389-001ABC00-450F-4A62-A94D-EE99626C5C56Q34221801-BD3C7153-5AD0-41B2-939E-CADAFC51EE58Q35333542-39936472-FA95-40EA-8678-1E89FE66AE1BQ35505126-2417B9ED-30AC-4313-BC05-7FE076CA7B26Q35740115-B78417F1-EAB7-4265-8B82-C0A5B056D8F7Q36081114-C125652D-87D7-4D11-A920-989F4AFA4C1DQ37091797-DC5B255A-8A41-4A6E-AF5C-E2F9EB180083Q37327734-48EFB9B8-0781-41AE-9BB2-B784F20AB49BQ37648125-2DE29891-7D6E-4A2C-8F4A-E79E803122CCQ38243378-C620547B-0D50-46E9-B2C9-71CE059E00C2Q38249887-52AAADFE-8DBA-4994-BD0B-8B06457DFDBDQ38253914-1F0FABD8-907E-4CBF-AE7A-5287FA25BB3DQ38264787-0EB13A8C-51B6-4786-AB4D-1FDD5AF7400FQ38601789-FD6DEFBB-6070-4B88-B1E2-4B1D358FF711Q38822694-776F8051-D8E0-49B0-8596-FDA8588E00AEQ38917058-F2516E75-376D-40CA-8550-239DB1F27FA7Q39112082-ACF69FE2-7A0E-438E-BFCD-91B7536DBDC7Q39123741-D22A0FFE-97C3-450B-AAE9-AE84AA079459Q39321673-49727E0E-7184-4C88-8FC7-24A54CC31B09Q40046633-7EAC47B1-90DE-415A-AF8E-7D413407C97BQ41040518-6B25EFEF-2CEB-4746-8A37-5E81E8FAD512Q42366441-B1281967-EE70-4D3A-9918-C5F90330A7B0Q47118235-3DF97E52-51E0-4EEC-B27B-A2FDCB5C3786Q47286778-CE2C7319-E0A4-43AD-9C64-BF2B4EFB1B48Q52647668-8BDE9473-BA19-4435-AA3A-0F1A0C0BEEA7Q53214174-E9D909AA-596A-4687-AA66-30EBF6A81D4AQ55394876-F78A1777-A154-4675-8BD0-733BCC80F033
P2860
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@ast
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@en
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@nl
type
label
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@ast
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@en
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@nl
prefLabel
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@ast
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@en
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
@nl
P2093
P2860
P1433
P1476
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma
@en
P2093
Alice Suk-Hang Cheng
Chartia Ching-Mei Cheung
Chun-Wai Ko
Grace Tin-Yun Chung
John Kong-Sang Woo
Kwong-Wai Choy
Margaret Heung-Ling Ng
Phyllis Fung Yi Cheung
P2860
P304
P356
10.1371/JOURNAL.PONE.0052426
P407
P577
2012-12-21T00:00:00Z